Release Date: 02/07/12 08:53 Summary: Security Facility Extension & Debt Reduction Price Sensitive: Yes Download Document 34.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%